Double-blind, placebo-controlled trial of flexible dose divalproex sodium [valproate semisodium] adjunctive to stimulant treatment for aggressive children with attention-deficit hyperactivity disorder

Trial Profile

Double-blind, placebo-controlled trial of flexible dose divalproex sodium [valproate semisodium] adjunctive to stimulant treatment for aggressive children with attention-deficit hyperactivity disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Aggression; Attention-deficit hyperactivity disorder; Behavioural disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2009 Results presented in the American Journal of Pscychiatry.
    • 27 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 19 Jul 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top